OUE Lippo Healthcare
OUE Lippo Healthcare Limited (“OUELH”) is a subsidiary company of OUE Limited. OUELH is a Pan-Asian healthcare group that owns, operates and invests in quality healthcare assets in high-growth Asian markets.
See below for the Latest OUELH News, Analysis, Profit Results, Share Price Information, and Commentary.
OUE Healthcare poised to capture foreign patient demand for specialist care services
OUE Healthcare poised to capture foreign patient demand for specialist care services
The healthcare group recently partnered with three medical specialist groups including two leading respiratory and cardiothoracic surgery specialist practices.
OUEH’s profit attributable to the company down nearly 80% in H1
Its revenue, however, increased 85% year-on-year (YoY) to $78.7m.
OUE Lippo Healthcare posts net loss of $4.01m in H2 22
For fiscal year 2022, its revenue grew to $119.8m YoY.
Most Read
1. Hong Kong seeks prescription for nursing shortage 2. Global pharmaceutical data and analytics market to double by 2028 3. ASEAN medical tourism set to outpace global revenue growth 4. Australia announces $25.5m 2024 Rapid Applied Research Translation grant 5. OUE Healthcare subsidiary secures majority stake in Rehab MattersResource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Events
Event News
The trade show, which was held in Singapore, successfully brought together over 13,000 visionary digital health innovators, government leaders, and industry pioneers from the medical and healthcare sectors.
